Peripheral Blood Stem Cell TransplantationStem CellsHematopoietic Stem Cell TransplantationTransplantation, AutologousAntineoplastic Combined Chemotherapy ProtocolsHematopoietic Stem Cell MobilizationHematopoietic Stem CellsTransplantation, HomologousGranulocyte Colony-Stimulating FactorStem Cell TransplantationLeukapheresisCord Blood Stem Cell TransplantationCombined Modality TherapyAntigens, CD34Blood Component RemovalCyclophosphamideTransplantation ConditioningEmbryonic Stem CellsTreatment OutcomeChemotherapy, AdjuvantGraft SurvivalBone Marrow TransplantationAdult Stem CellsHematologic NeoplasmsMelphalanGraft vs Host DiseasePluripotent Stem CellsTissue DonorsEtoposideStem Cell NicheMultiple MyelomaKidney TransplantationCell DifferentiationAntineoplastic AgentsBusulfanDisease-Free SurvivalDoxorubicinAntineoplastic Agents, AlkylatingNeural Stem CellsSurvival RateBlood CellsInduced Pluripotent Stem CellsLymphoma, Non-HodgkinSurvival AnalysisHematopoiesisImmunosuppressive AgentsRecurrenceTime FactorsStem Cell FactorBlood Cell CountThiotepaFetal BloodCisplatinMesenchymal Stem Cell TransplantationMultipotent Stem CellsIfosfamideMesenchymal Stromal CellsSalvage TherapyWhole-Body IrradiationHistocompatibilityCell LineageCytarabineHistocompatibility TestingNeoplasmsBreast NeoplasmsTransplantsMyeloablative AgonistsTransplantation ChimeraLeukemiaFollow-Up StudiesBone Marrow CellsPrognosisHodgkin DiseaseInfectionCarboplatinRetrospective StudiesColony-Forming Units AssayMethotrexateRemission InductionGraft RejectionCell SeparationCells, CulturedLeukemia, Myeloid, AcuteFlow CytometryDrug Administration ScheduleBone MarrowVidarabineLymphomaHematologic DiseasesPlatelet CountProspective StudiesCyclosporineBone Marrow PurgingStem Cell ResearchCytomegalovirus InfectionsRecombinant ProteinsCell ProliferationBlood DonorsNeutropeniaPlant Stems